Defibrillators Market 2018 | Revenue Opportunities By Top Players Medtronic, St. Jude Medical, Koninklijke Philips N.V., Schiller AG, Cardioline SpA, Mindray Medical, ZOLL Medical Corporation, Boston Scientific Corporation, GE Healthcare, Bexen Cardio

Defibrillator is an essential tool in cardiopulmonary resuscitation indicated in cardiac arrhythmia. Various advancements have been observed in defibrillator technology – from manual to automated ones, and implantable defibrillators to ensure constant care for patients suffering from ischemic heart disease or those at high risk of cardiac arrest. A Global Resuscitation Alliance (GRA) was formed in 2016, comprising international health organizations, global resuscitation leaders, and the American Heart Association (AHA), with an objective to increase the survival rate of patients with sudden cardiac arrest, by 50%. This alliance actively works towards increasing public awareness about defibrillators and has facilitated the installation of automated defibrillators in public places for use in case of related medical emergencies. Training initiatives such as by-stander PCR training by manufacturers would considerably contribute towards improvement in survival rates, while enhancing brand visibility.

Request Free Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/115

Onboard emergency medical cases lead to major losses to airlines. Emirates handled more than 60 flight diversions in 2016 due to medical emergency and it is estimated that a single diversion could lead to losses ranging from US$ 50,000 to US$ 600,000. The airline therefore decided to set standards for emergency medical care in 2016 and have invested US$ 7 million for installing medical equipment on board which also include defibrillators.

The global defibrillators market was valued at US$ 11,820 million in 2015.

According to a report by the Institute of Medicine in 2015, around 600 thousand people in the U.S. suffer from cardiac arrest annually, with over 65% of the cases in out-of-hospital settings. The survival rate of out-of-hospital setting is less than 6%, while it is 24% in hospital settings. The survival rate in out-of-hospital setting is less due to consumer’s lack of operational knowledge about defibrillators and about carrying out CPR. Therefore, various training initiatives associated with the use of defibrillators and CPR techniques has led to increasing demand for defibrillators, especially the automated ones, thereby driving growth of the market. Individuals and staffs in malls were given training on how to use defibrillators by the UAE government, who deployed defibrillators in the country. According to the American Heart Association, lack of availability of trained/skilled by-stander at the emergency site is the major factor for less survival rate of patients who suffer from sudden cardiac arrest by 7% - 10% with every minute of delay until defibrillation. Therefore, initiatives to increase awareness and accessibility to the device is expected to fuel the defibrillators market growth.

Various manufacturers of defibrillators and government and non-governmental organizations have installed these life-saving devices in public and private places such as schools, airports, and malls in the markets such as the U.S., Canada, Australia, UAE and U.K., called as public access defibrillator (PAD). The UAE government deployed 82 automated external defibrillators (AED) in February 2016 across different locations in the country. Besides, a student at Delft University of Technology, Netherlands, has created a drone that carries defibrillator to the emergency site. While this is still pretty much a prototype, further research on this can significantly reduce development and installation costs of PAD, while significantly enhancing reach of defibrillators in emergency medical scenarios even in hard to reach remote locations.

Get PDF Brochure for Research Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/115

Defibrillators have improved significantly in terms of cost, size reduction and ease of operation. Two of the most important of these advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices help prevent cardiac attacks, with little or no external assistance irrespective of the time and location in case of any major variations in heartbeat. However, cases of inappropriate functioning leading to hospitalization or even death of the patient has led to implementation of stringent regulations for approval and usage of the devices at potential patient sites. The U.S. FDA in 2015 issued an order to include pre-marketing approval (PMA) submission for all the prevalent and new defibrillators.

Key companies covered as a part of this study include Medtronic, St. Jude Medical, Koninklijke Philips N.V., Schiller AG, Cardioline SpA, Mindray Medical, ZOLL Medical Corporation, Boston Scientific Corporation, GE Healthcare and Bexen Cardio

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.